TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

Graham Capital Management, L.P.'s Holding History (CIK: 0001315421)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 22,238,000 Value ($000) $25,131 Avg Close — Range —
Q2 2025
Shares 41,667,000 Value ($000) $39,748 Avg Close — Range —
Q1 2025
Shares 20,762,000 Value ($000) $20,749 Avg Close — Range —
Q4 2024
Shares 38,262,000 Value ($000) $36,153 Avg Close — Range —
Q3 2024
Shares 15,500,000 Value ($000) $13,424 Avg Close — Range —